Copyright
©The Author(s) 2024.
World J Clin Cases. Jun 26, 2024; 12(18): 3385-3394
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3385
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3385
Figure 2 Prognostic nomogram used to predict the 1-year, 1.
5-year, and 2-year probability of postoperative recurrence-free survival in patients with endometrial cancer. ctDNA: Circulating tumor DNA; CA125: Carcinoembryonic antigen 125.
- Citation: Liu Y, Lu XN, Guo HM, Bao C, Zhang J, Jin YN. Development and validation of a circulating tumor DNA-based optimization-prediction model for short-term postoperative recurrence of endometrial cancer. World J Clin Cases 2024; 12(18): 3385-3394
- URL: https://www.wjgnet.com/2307-8960/full/v12/i18/3385.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i18.3385